Erratum: The Post-Synaptic Density of Human Postmortem Brain Tissues: An Experimental Study Paradigm for Neuropsychiatric Illnesses (PLOS ONE (2009) 4:4 (e5251) DOI: 10.1371/journal.pone.0005251);The post-synaptic density of human postmortem brain tissues: An experimental study paradigm for neuropsychiatric illnesses

PLoS ONE

Volumn 4, Issue 4, 2009, Pages

  Hahn, Chang Gyu ^a   Banerjee, Anamika ^a   MacDonald, Matthew L ^a,b   Cho, Dan Sung ^a   Kamins, Joshua ^a   Nie, Zhiping ^a   Borgmann Winter, Karin E ^a,d   Grosser, Tilo ^b   Pizarro, Angel ^b   Ciccimaro, Eugene ^d   Arnold, Steven E ^a   Wang, Hoau Yan ^c   Blair, Ian A ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c CITY UNIVERSITY OF NEW YORK MEDICAL SCHOOL   (United States)

^d CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BRAIN SYNAPTOSOME; BRAIN TISSUE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOPRECIPITATION; MENTAL DISEASE; NEUROLOGIC DISEASE; PROTEIN ANALYSIS; PROTEIN PROTEIN INTERACTION; SYNAPSE; SYNAPTIC MEMBRANE; TANDEM MASS SPECTROMETRY; BRAIN LEVEL; CADAVER; CELL FRACTIONATION; CHEMISTRY; ISOLATION AND PURIFICATION; PATHOPHYSIOLOGY; SYNAPTOSOME; ULTRASTRUCTURE;

MULTIPROTEIN COMPLEX; NERVE PROTEIN; PEPTIDE; POSTSYNAPTIC DENSITY PROTEINS;

BRAIN CHEMISTRY; CADAVER; HUMANS; MULTIPROTEIN COMPLEXES; NERVE TISSUE PROTEINS; NERVOUS SYSTEM DISEASES; PEPTIDES; SUBCELLULAR FRACTIONS; SYNAPTIC MEMBRANES; SYNAPTOSOMES;

EID: 65349183500     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0274661     Document Type: Erratum

References (47)

1. Eastwood SL (2004) The synaptic pathology of schizophrenia: is aberrant neurodevelopment and plasticity to blame? Int Rev Neurobiol 59: 47-72.
2. Harrison PJ, Eastwood SL (2001) Neuropathological studies of synaptic connectivity in the hippocampal formation in schizophrenia. Hippocampus 11: 508-519.
3. Harrison PJ, Lyon L, Sartorius LJ, Burnet PW, Lane TA (2008) The group II metabotropic glutamate receptor 3 (mGluR3, mGlu3, GRM3): expression, function and involvement in schizophrenia. J Psychopharmacol 22: 308-322.
4. Honer WG, Young CE (2004) Presynaptic proteins and schizophrenia. Int Rev Neurobiol 59: 175-199.
5. Lewis DA, Moghaddam B (2006) Cognitive dysfunction in schizophrenia: convergence of gamma-aminobutyric acid and glutamate alterations. Arch Neurol 63: 1372-1376.
6. Mirnics K, Middleton FA, Lewis DA, Levitt P (2001) Analysis of complex brain disorders with gene expression microarrays: schizophrenia as a disease of the synapse. Trends Neurosci 24: 479-486.
7. Harrison PJ, Weinberger DR (2005) Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Mol Psychiatry 10: 40-68; image 45.
8. Seagar M, Leveque C, Charvin N, Marqueze B, Martin-Moutot N, et al. (1999) Interactions between proteins implicated in exocytosis and voltage-gated calcium channels. Philos Trans R Soc Lond B Biol Sci 354: 289-297.
9. Seagar M, Takahashi M (1998) Interactions between presynaptic calcium channels and proteins implicated in synaptic vesicle trafficking and exocytosis. J Bioenerg Biomembr 30: 347-356.
10. Okabe S (2007) Molecular anatomy of the postsynaptic density. Mol Cell Neurosci 34: 503-518.
11. Sheng M (2001) Molecular organization of the postsynaptic specialization. Proc Natl Acad Sci U S A 98: 7058-7061.
12. Tomita S, Nicoll RA, Bredt DS (2001) PDZ protein interactions regulating glutamate receptor function and plasticity. J Cell Biol 153: F19-24.
13. Hashimoto R, Tankou S, Takeda M, Sawa A (2007) Postsynaptic density: a key convergent site for schizophrenia susceptibility factors and possible target for drug development. Drugs Today (Barc) 43: 645-654.
14. Phillips GR, Florens L, Tanaka H, Khaing ZZ, Fidler L, et al. (2005) Proteomic comparison of two fractions derived from the transsynaptic scaffold. J Neurosci Res 81: 762-775.
15. Trinidad JC, Thalhammer A, Specht CG, Lynn AJ, Baker PR, et al. (2008) Quantitative analysis of synaptic phosphorylation and protein expression. Mol Cell Proteomics 7: 684-696.
16. Dosemeci A, Makusky AJ, Jankowska-Stephens E, Yang X, Slotta DJ, et al. (2007) Composition of the synaptic PSD-95 complex. Mol Cell Proteomics 6: 1749-1760.
17. Dosemeci A, Tao-Cheng JH, Vinade L, Jaffe H (2006) Preparation of postsynaptic density fraction from hippocampal slices and proteomic analysis. Biochem Biophys Res Commun 339: 687-694.
18. Behan A, Byrne C, Dunn MJ, Cagney G, Cotter DR (2008) Proteomic analysis of membrane microdomain-associated proteins in the dorsolateral prefrontal cortex in schizophrenia and bipolar disorder reveals alterations in LAMP, STXBP1 and BASP1 protein expression. Mol Psychiatry.
19. Talbot K, Cho DS, Ong WY, Benson MA, Han LY, et al. (2006) Dysbindin-1 is a synaptic and microtubular protein that binds brain snapin. Hum Mol Genet 15: 3041-3054.
20. Kennedy MB (2000) Signal-processing machines at the postsynaptic density. Science 290: 750-754.
21. Sheng M, Sala C (2001) PDZ domains and the organization of supramolecular complexes. Annu Rev Neurosci 24: 1-29.
22. Sheng M, Hoogenraad CC (2007) The postsynaptic architecture of excitatory synapses: a more quantitative view. Annu Rev Biochem 76: 823-847.
23. Kim E, Sheng M (2004) PDZ domain proteins of synapses. Nat Rev Neurosci 5: 771-781.
24. Cotman CW, Banker G, Churchill L, Taylor D (1974) Isolation of postsynaptic densities from rat brain. J Cell Biol 63: 441-455.
25. Carlin RK, Grab DJ, Cohen RS, Siekevitz P (1980) Isolation and characterization of postsynaptic densities from various brain regions: enrichment of different types of postsynaptic densities. J Cell Biol 86: 831-845.
26. Phillips GR, Huang JK, Wang Y, Tanaka H, Shapiro L, et al. (2001) The presynaptic particle web: ultrastructure, composition, dissolution, and reconstitution. Neuron 32: 63-77.
27. Phillips GR, Tanaka H, Frank M, Elste A, Fidler L, et al. (2003) Gamma-protocadherins are targeted to subsets of synapses and intracellular organelles in neurons. J Neurosci 23: 5096-5104.
28. Yoshimura Y, Yamauchi Y, Shinkawa T, Taoka M, Donai H, et al. (2004) Molecular constituents of the postsynaptic density fraction revealed by proteomic analysis using multidimensional liquid chromatography-tandem mass spectrometry. J Neurochem 88: 759-768.
29. Walikonis RS, Jensen ON, Mann M, Provance DW Jr, Mercer JA, et al. (2000) Identification of proteins in the postsynaptic density fraction by mass spectrometry. J Neurosci 20: 4069-4080.
30. Cheng D, Hoogenraad CC, Rush J, Ramm E, Schlager MA, et al. (2006) Relative and absolute quantification of postsynaptic density proteome isolated from rat forebrain and cerebellum. Mol Cell Proteomics 5: 1158-1170.
31. Peng J, Kim MJ, Cheng D, Duong DM, Gygi SP, et al. (2004) Semiquantitative proteomic analysis of rat forebrain postsynaptic density fractions by mass spectrometry. J Biol Chem 279: 21003-21011.
32. Jaffe H, Vinade L, Dosemeci A (2004) Identification of novel phosphorylation sites on postsynaptic density proteins. Biochem Biophys Res Commun 321: 210-218.
33. Lewis DA (2002) The human brain revisited: opportunities and challenges in postmortem studies of psychiatric disorders. Neuropsychopharmacology 26: 143-154.
34. Crecelius A, Gotz A, Arzberger T, Frohlich T, Arnold GJ, et al. (2008) Assessing quantitative post-mortem changes in the gray matter of the human frontal cortex proteome by 2-D DIGE. Proteomics 8: 1276-1291.
35. Hunsucker SW, Solomon B, Gawryluk J, Geiger JD, Vacano GN, et al. (2008) Assessment of post-mortem-induced changes to the mouse brain proteome. J Neurochem 105: 725-737.
36. Novikova SI, He F, Cutrufello NJ, Lidow MS (2006) Identification of protein biomarkers for schizophrenia and bipolar disorder in the postmortem prefrontal cortex using SELDI-TOF-MS ProteinChip profiling combined with MALDI-TOF-PSD-MS analysis. Neurobiol Dis 23: 61-76.
37. Leliveld SR, Bader V, Hendriks P, Prikulis I, Sajnani G, et al. (2008) Insolubility of disrupted-in-schizophrenia 1 disrupts oligomer-dependent interactions with nuclear distribution element 1 and is associated with sporadic mental disease. J Neurosci 28: 3839-3845.
38. Price TS, Lucitt MB, Wu W, Austin DJ, Pizarro A, et al. (2007) EBP, a program for protein identification using multiple tandem mass spectrometry datasets. Mol Cell Proteomics 6: 527-536.
39. Collins MO, Husi H, Yu L, Brandon JM, Anderson CN, et al. (2006) Molecular characterization and comparison of the components and multiprotein complexes in the postsynaptic proteome. J Neurochem 97 Suppl 1: 16-23.
40. Coyle JT (2006) Glutamate and schizophrenia: beyond the dopamine hypothesis. Cell Mol Neurobiol 26: 365-384.
41. Heresco-Levy U, Javitt DC (1998) The role of N-methyl-D-aspartate (NMDA) receptor-mediated neurotransmission in the pathophysiology and therapeutics of psychiatric syndromes. Eur Neuropsychopharmacol 8: 141-152.
42. Meador-Woodruff JH, Clinton SM, Beneyto M, McCullumsmith RE (2003) Molecular abnormalities of the glutamate synapse in the thalamus in schizophrenia. Ann N Y Acad Sci 1003: 75-93.
43. Tsai G, Coyle JT (2002) Glutamatergic mechanisms in schizophrenia. Annu Rev Pharmacol Toxicol 42: 165-179.
44. Chen X, Vinade L, Leapman RD, Petersen JD, Nakagawa T, et al. (2005) Mass of the postsynaptic density and enumeration of three key molecules. Proc Natl Acad Sci U S A 102: 11551-11556.
45. Petersen JD, Chen X, Vinade L, Dosemeci A, Lisman JE, et al. (2003) Distribution of postsynaptic density (PSD)-95 and Ca2+/ calmodulin-dependent protein kinase II at the PSD. J Neurosci 23: 11270-11278.
46. Husi H, Ward MA, Choudhary JS, Blackstock WP, Grant SG (2000) Proteomic analysis of NMDA receptor-adhesion protein signaling complexes. Nat Neurosci 3: 661-669.
47. Keller A, Nesvizhskii AI, Kolker E, Aebersold R (2002) Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search. Anal Chem 74: 5383-5392.